Note: All prices and reports are based on end of the day (EOD) data.
Lupin Limited (LUPIN)
What LUPIN does

Lupin Limited

What company does?Pharmaceutical manufacturing and distribution
Established1968
Entity typePrivate
HeadquartersIndia
SegmentB2B, B2C
Lupin Limited is a share market listed company in the Pharmaceuticals industry . It got listed on NSE on 10-SEP-2001 under the trading symbol LUPIN. On BSE it is listed under trading symbol LUPIN. The company operates in Pharmaceuticals , Healthcare and Biotechnology categories.

Company overview

Lupin Limited is a multinational pharmaceutical company based in Mumbai, India. Founded in 1968, Lupin has grown to become one of the largest and most reputable pharmaceutical companies globally. The company specializes in the development, manufacturing, and marketing of a wide range of generic and branded formulations, biotechnology products, active pharmaceutical ingredients (APIs), and specialty drugs across various therapeutic areas including cardiovascular, central nervous system, dermatology, diabetes, oncology, respiratory disorders, and more. With a strong focus on research and development (R&D), Lupin has been at the forefront of innovation in the pharmaceutical industry. It has established itself as an industry leader by consistently delivering high-quality medications that meet stringent regulatory standards. Additionally,

it utilizes advanced technologies for drug discovery and development processes.

One key factor that sets Lupin apart from its competitors is its robust global presence. The company operates in numerous markets worldwide with a significant market share in several countries such as the United States, India, Japan, South Africa, and many others.

This extensive footprint allows Lupin to cater to diverse patient populations around the world while maintaining a strong competitive edge.

As part of its commitment to excellence,

Lupin actively engages in strategic collaborations and partnerships

, both domestically and internationally. These alliances enable the company to access new technologies, expand its product portfolio, and enhance its overall competitiveness within the rapidly evolving pharmaceutical landscape. In conclusion,Lupin Limited's relentless pursuit of innovation combined with its expansive global reach positions it as a formidable player in the pharmaceutical industry. Through its diversified product offerings commitment to R&D,and strategic partnerships,the company continues to make significant contributions towards improving global healthcare outcomes.
Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.